MYC and acute lymphoblastic leukemia: GCS-3/dexamethasone-induced upregulation of BIM was inhibited by RU486; therefore, BIM upregulation correlates with GCS-3/dexamethasone combination efficacy and BIM does not appear to be a target of C-MYC in ALL-19 or ALL-54.